(Q57416513)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9093250%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

Randomised trial of oral and intravenous methylprednisolone in acute relapses of multiple sclerosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9093250%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

0 references

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9093250%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9093250%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9093250%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

D Barnes

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9093250%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

O Wade-Jones

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9093250%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

T Britton

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9093250%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

P Rudge

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9093250%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

M Swash

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9093250%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

H Katifi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9093250%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

J Frankel

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9093250%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

R A Hughes

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9093250%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

D A Francis

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9093250%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

G D Perkin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9093250%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

language of work or name

English

0 references

publication date

1 March 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9093250%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9093250%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

349

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9093250%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

9056

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9093250%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

902-906

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9093250%20AND%20SRC:MED&resulttype=core&format=json

Multiple sclerosis. Treatment of acute exacerbations with corticotrophin (A.C.T.H.)

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2906453-7

7 January 2021

A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 1. Clinical effects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2906453-7

7 January 2021

Methylprednisolone in multiple sclerosis: a comparison of oral with intravenous therapy at equivalent high dose

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2906453-7

7 January 2021

The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2906453-7

7 January 2021

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2906453-7

7 January 2021

Relative efficacy of intravenous methylprednisolone and ACTH in the treatment of acute relapse in MS

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2906453-7

7 January 2021

Analysis of serial measurements in medical research

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2906453-7

7 January 2021

Double-blind trial of dexamethasone versus methylprednisolone in multiple sclerosis acute relapses.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2906453-7

7 January 2021

Intravenous methylprednisolone for multiple sclerosis in relapse

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2906453-7

7 January 2021

Megadose corticosteroids in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2906453-7

7 January 2021

High dose steroids in acute relapses of multiple sclerosis: MRI evidence for a possible mechanism of therapeutic effect

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2906453-7

7 January 2021

Quantitative MRI changes in gadolinium-DTPA enhancement after high-dose intravenous methylprednisolone in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2906453-7

7 January 2021

A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2906453-7

7 January 2021

The optic neuritis treatment trial: three-year follow-up results

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2906453-7

7 January 2021

Methylprednisolone Infusion during Acute Exacerbation of MS: Plasma and CSF Concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2906453-7

7 January 2021

Methylprednisolone therapy in multiple sclerosis: a profile of adverse effects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2906453-7

7 January 2021

10.1016/S0140-6736(96)06453-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9093250%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9093250%20AND%20SRC:MED&resulttype=core&format=json